| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8755222 | Auris Nasus Larynx | 2015 | 5 Pages |
Abstract
These results indicated that a novel non-antibiotic macrolide, EM900 exerted direct inhibitory effects on mucus secretion from airway epithelial cells, and that it may have the potential to become a new anti-inflammatory drug for the treatment of chronic rhinosinusitis.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Ichiro Tojima, Shino Shimizu, Takao Ogawa, Hideaki Kouzaki, Satoshi Omura, Toshiaki Sunazuka, Takeshi Shimizu,